Moderna

A lab technician sorts blood samples for a COVID-19 vaccination study at the Research Centers of America in Hollywood, Fla., on Aug. 13.

Health

Vaccine Expert: Once COVID-19 Vaccine Is Available, 'Don't Overthink It. Don't Wait'

Terry Gross

Dr. Peter Hotez is part of a team working to develop a low-cost COVID vaccine that could be distributed globally. "Vaccines are coming," he says. "We have to get everybody through to the other side."

Moncef Slaoui, chief scientific adviser for Operation Warp Speed, listens as President Trump delivers remarks about coronavirus vaccine development in the Rose Garden on May 15. Slaoui says Americans could start seeing a vaccine by the middle of December.

Health

Americans Could See A Vaccine By Mid-December, Says Operation Warp Speed Adviser

Christianna Silva

Moncef Slaoui, the chief scientific adviser for Operation Warp Speed, says that some Americans could start receiving a COVID-19 vaccine by the second week of December.

Some of the world's largest vaccine-makers hope to bolster public confidence in a yet-to-arrive COVID-19 vaccine, pledging to follow strict safety protocols in the rush to respond to the pandemic. Here, a nurse practitioner administers a dose of flu vaccine in Key Biscayne, Fla.

Health

9 Drugmakers Sign Safety Pledge In Rush To Develop Coronavirus Vaccine

Bill Chappell

The pledge comes one month after a survey found that only 2 in 5 Americans said they planned to get vaccinated against COVID-19.

Director of the National Institutes of Health, Dr. Francis Collins, holds a model of the coronavirus. This is the sixth vaccine candidate to join Operation Warp Speed's portfolio, and the largest vaccine deal to date.

Government & Politics

U.S. Reaches $2.1 Billion Deal With Sanofi, GlaxoSmithKline For COVID-19 Vaccine Push

Sydney Lupkin

This is the sixth vaccine candidate to join Operation Warp Speed's portfolio, and the largest vaccine deal to date.

The agreement also would allow the federal government to acquire an additional 500 million doses of the Pfizer vaccine.

Government & Politics

U.S. To Get 100 Million Doses of Pfizer Coronavirus Vaccine In $1.95 Billion Deal

Sydney Lupkin

If the company's vaccine candidate pans out, Americans can receive it for free under the deal. The arrangement is part of the U.S. government's push to have a vaccine widely available by January.